HEADER    PROTEIN FIBRIL                          03-MAY-17   5VOS              
TITLE     VGSNKGAIIGL FROM AMYLOID BETA DETERMINED BY MICROED                   
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: AMYLOID BETA A4 PROTEIN;                                   
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: VGSNKGAIIGL PEPTIDE (RESIDUES 24-34, UNP RESIDUES 7-17);   
COMPND   5 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 SYNTHETIC: YES;                                                      
SOURCE   3 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   4 ORGANISM_COMMON: HUMAN;                                              
SOURCE   5 ORGANISM_TAXID: 9606                                                 
KEYWDS    AMYLOID, STERIC ZIPPER, PROTEIN FIBRIL                                
EXPDTA    ELECTRON CRYSTALLOGRAPHY                                              
AUTHOR    J.A.RODRIGUEZ,M.R.SAWAYA,D.CASCIO,D.S.EISENBERG,S.L.GRINER,T.GONEN    
REVDAT   7   30-JUN-21 5VOS    1       REMARK                                   
REVDAT   6   20-NOV-19 5VOS    1       REMARK                                   
REVDAT   5   06-JUN-18 5VOS    1       REMARK                                   
REVDAT   4   25-APR-18 5VOS    1       REMARK                                   
REVDAT   3   07-MAR-18 5VOS    1       JRNL                                     
REVDAT   2   10-JAN-18 5VOS    1       JRNL                                     
REVDAT   1   03-JAN-18 5VOS    0                                                
JRNL        AUTH   P.KROTEE,S.L.GRINER,M.R.SAWAYA,D.CASCIO,J.A.RODRIGUEZ,D.SHI, 
JRNL        AUTH 2 S.PHILIPP,K.MURRAY,L.SAELICES,J.LEE,P.SEIDLER,C.G.GLABE,     
JRNL        AUTH 3 L.JIANG,T.GONEN,D.S.EISENBERG                                
JRNL        TITL   COMMON FIBRILLAR SPINES OF AMYLOID-BETA AND HUMAN ISLET      
JRNL        TITL 2 AMYLOID POLYPEPTIDE REVEALED BY MICROELECTRON DIFFRACTION    
JRNL        TITL 3 AND STRUCTURE-BASED INHIBITORS.                              
JRNL        REF    J. BIOL. CHEM.                V. 293  2888 2018              
JRNL        REFN                   ESSN 1083-351X                               
JRNL        PMID   29282295                                                     
JRNL        DOI    10.1074/JBC.M117.806109                                      
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.42 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : REFMAC                                               
REMARK   3   AUTHORS     : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,              
REMARK   3               : NICHOLLS,WINN,LONG,VAGIN                             
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.42                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 32.96                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 85.5                           
REMARK   3   NUMBER OF REFLECTIONS             : 1014                           
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.239                           
REMARK   3   R VALUE            (WORKING SET) : 0.234                           
REMARK   3   FREE R VALUE                     : 0.292                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 10.000                          
REMARK   3   FREE R VALUE TEST SET COUNT      : 113                             
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 72                                      
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 0                                       
REMARK   3   SOLVENT ATOMS            : 1                                       
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 14.64                          
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 13.17                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : 1.04000                                              
REMARK   3    B22 (A**2) : -1.30000                                             
REMARK   3    B33 (A**2) : -0.04000                                             
REMARK   3    B12 (A**2) : 0.00000                                              
REMARK   3    B13 (A**2) : 0.83000                                              
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED OVERALL COORDINATE ERROR.                                 
REMARK   3   ESU BASED ON R VALUE                            (A): 0.115         
REMARK   3   ESU BASED ON FREE R VALUE                       (A): 0.122         
REMARK   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.100         
REMARK   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.871         
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   
REMARK   3   DISTANCE RESTRAINTS.                    RMS    SIGMA               
REMARK   3    BOND LENGTH                     (A) : NULL  ; NULL                
REMARK   3    ANGLE DISTANCE                  (A) : NULL  ; NULL                
REMARK   3    INTRAPLANAR 1-4 DISTANCE        (A) : NULL  ; NULL                
REMARK   3    H-BOND OR METAL COORDINATION    (A) : NULL  ; NULL                
REMARK   3                                                                      
REMARK   3   PLANE RESTRAINT                  (A) : NULL  ; NULL                
REMARK   3   CHIRAL-CENTER RESTRAINT       (A**3) : NULL  ; NULL                
REMARK   3                                                                      
REMARK   3   NON-BONDED CONTACT RESTRAINTS.                                     
REMARK   3    SINGLE TORSION                  (A) : NULL  ; NULL                
REMARK   3    MULTIPLE TORSION                (A) : NULL  ; NULL                
REMARK   3    H-BOND (X...Y)                  (A) : NULL  ; NULL                
REMARK   3    H-BOND (X-H...Y)                (A) : NULL  ; NULL                
REMARK   3                                                                      
REMARK   3   CONFORMATIONAL TORSION ANGLE RESTRAINTS.                           
REMARK   3    SPECIFIED                 (DEGREES) : NULL  ; NULL                
REMARK   3    PLANAR                    (DEGREES) : NULL  ; NULL                
REMARK   3    STAGGERED                 (DEGREES) : NULL  ; NULL                
REMARK   3    TRANSVERSE                (DEGREES) : NULL  ; NULL                
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                
REMARK   3   MAIN-CHAIN BOND              (A**2) : NULL  ; NULL                 
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : NULL  ; NULL                 
REMARK   3   SIDE-CHAIN BOND              (A**2) : NULL  ; NULL                 
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING   
REMARK   3  POSITIONS U VALUES : REFINED INDIVIDUALLY                           
REMARK   4                                                                      
REMARK   4 5VOS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-MAY-17.                  
REMARK 100 THE DEPOSITION ID IS D_1000227781.                                   
REMARK 240                                                                      
REMARK 240 EXPERIMENTAL DETAILS                                                 
REMARK 240   RECONSTRUCTION METHOD          : CRYSTALLOGRAPHY                   
REMARK 240   SAMPLE TYPE                    : 3D ARRAY                          
REMARK 240   SPECIMEN TYPE                  : NULL                              
REMARK 240 DATA ACQUISITION                                                     
REMARK 240   DATE OF DATA COLLECTION        : 17-APR-15                         
REMARK 240   TEMPERATURE           (KELVIN) : 100.0                             
REMARK 240   PH                             : 4.00                              
REMARK 240   NUMBER OF CRYSTALS USED        : NULL                              
REMARK 240   MICROSCOPE MODEL               : FEI TECNAI F20                    
REMARK 240   DETECTOR TYPE                  : TVIPS TEMCAM-F416 (4K X 4K)       
REMARK 240   ACCELERATION VOLTAGE (KV)      : 200                               
REMARK 240   NUMBER OF UNIQUE REFLECTIONS   : 1129                              
REMARK 240   RESOLUTION RANGE HIGH      (A) : 1.420                             
REMARK 240   RESOLUTION RANGE LOW       (A) : 32.960                            
REMARK 240   DATA SCALING SOFTWARE          : XSCALE                            
REMARK 240   COMPLETENESS FOR RANGE     (%) : 85.5                              
REMARK 240   DATA REDUNDANCY                : 5.175                             
REMARK 240 IN THE HIGHEST RESOLUTION SHELL                                      
REMARK 240   HIGHEST RESOLUTION SHELL, RANGE HIGH (A) :1.42                     
REMARK 240   HIGHEST RESOLUTION SHELL, RANGE LOW  (A) :1.49                     
REMARK 240   COMPLETENESS FOR SHELL     (%) : 47.5                              
REMARK 240   DATA REDUNDANCY IN SHELL       : 2.57                              
REMARK 240   R MERGE FOR SHELL          (I) : 0.49600                           
REMARK 240   METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT      
REMARK 240   SOFTWARE USED                  : PHASER                            
REMARK 240   STARTING MODEL                 : NULL                              
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1                         
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,Y+1/2,-Z                                             
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000        2.36500            
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DECAMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   2  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   2  0.000000  1.000000  0.000000        4.73000            
REMARK 350   BIOMT3   2  0.000000  0.000000  1.000000        0.00000            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   3  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   3  0.000000  1.000000  0.000000        9.46000            
REMARK 350   BIOMT3   3  0.000000  0.000000  1.000000        0.00000            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   4  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   4  0.000000  1.000000  0.000000       -4.73000            
REMARK 350   BIOMT3   4  0.000000  0.000000  1.000000        0.00000            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   5  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   5  0.000000  1.000000  0.000000       -9.46000            
REMARK 350   BIOMT3   5  0.000000  0.000000  1.000000        0.00000            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   6 -1.000000  0.000000  0.000000        1.30947            
REMARK 350   BIOMT2   6  0.000000  1.000000  0.000000        2.36500            
REMARK 350   BIOMT3   6  0.000000  0.000000 -1.000000       98.87845            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   7 -1.000000  0.000000  0.000000        1.30947            
REMARK 350   BIOMT2   7  0.000000  1.000000  0.000000        7.09500            
REMARK 350   BIOMT3   7  0.000000  0.000000 -1.000000       98.87845            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   8 -1.000000  0.000000  0.000000        1.30947            
REMARK 350   BIOMT2   8  0.000000  1.000000  0.000000       11.82500            
REMARK 350   BIOMT3   8  0.000000  0.000000 -1.000000       98.87845            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   9 -1.000000  0.000000  0.000000        1.30947            
REMARK 350   BIOMT2   9  0.000000  1.000000  0.000000       -2.36500            
REMARK 350   BIOMT3   9  0.000000  0.000000 -1.000000       98.87845            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1  10 -1.000000  0.000000  0.000000        1.30947            
REMARK 350   BIOMT2  10  0.000000  1.000000  0.000000       -7.09500            
REMARK 350   BIOMT3  10  0.000000  0.000000 -1.000000       98.87845            
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 5KNZ   RELATED DB: PDB                                   
REMARK 900 HOMOLOGOUS SEQUENCE FROM HIAPP                                       
REMARK 900 RELATED ID: EMD-8720   RELATED DB: EMDB                              
REMARK 900 VGSNKGAIIGL FROM AMYLOID BETA DETERMINED BY MICROED                  
DBREF  5VOS A   24    34  UNP    L7XCZ9   L7XCZ9_HUMAN     7     17             
SEQRES   1 A   11  VAL GLY SER ASN LYS GLY ALA ILE ILE GLY LEU                  
FORMUL   2  HOH   *(H2 O)                                                       
CRYST1   18.780    4.730   33.470  90.00 100.02  90.00 P 1 21 1      2          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.053248  0.000000  0.009405        0.00000                         
SCALE2      0.000000  0.211416  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.030340        0.00000                         
ATOM      1  N   VAL A  24       9.585  -0.410  36.450  1.00 18.03           N  
ATOM      2  CA  VAL A  24       8.348  -1.211  36.293  1.00 17.53           C  
ATOM      3  C   VAL A  24       7.375  -0.492  35.356  1.00 13.69           C  
ATOM      4  O   VAL A  24       7.456   0.703  35.197  1.00 13.25           O  
ATOM      5  CB  VAL A  24       7.754  -1.499  37.685  1.00 18.06           C  
ATOM      6  CG1 VAL A  24       7.607  -0.226  38.435  1.00 20.35           C  
ATOM      7  CG2 VAL A  24       6.389  -2.147  37.632  1.00 20.65           C  
ATOM      8  N   GLY A  25       6.514  -1.238  34.667  1.00 10.67           N  
ATOM      9  CA  GLY A  25       5.526  -0.630  33.774  1.00  8.87           C  
ATOM     10  C   GLY A  25       4.452   0.077  34.545  1.00  7.23           C  
ATOM     11  O   GLY A  25       4.229   1.277  34.381  1.00  7.12           O  
ATOM     12  N   SER A  26       3.788  -0.685  35.396  1.00  6.65           N  
ATOM     13  CA  SER A  26       2.693  -0.181  36.209  1.00  6.64           C  
ATOM     14  C   SER A  26       2.872  -0.705  37.612  1.00  5.64           C  
ATOM     15  O   SER A  26       3.074  -1.883  37.788  1.00  6.33           O  
ATOM     16  CB  SER A  26       1.346  -0.647  35.627  1.00  7.02           C  
ATOM     17  OG  SER A  26       0.268  -0.552  36.548  1.00  9.40           O  
ATOM     18  N   ASN A  27       2.853   0.174  38.607  1.00  5.63           N  
ATOM     19  CA  ASN A  27       2.808  -0.290  39.974  1.00  5.53           C  
ATOM     20  C   ASN A  27       1.560   0.286  40.581  1.00  5.96           C  
ATOM     21  O   ASN A  27       1.388   1.485  40.533  1.00  5.61           O  
ATOM     22  CB  ASN A  27       4.049   0.167  40.769  1.00  5.80           C  
ATOM     23  CG  ASN A  27       4.150  -0.487  42.128  1.00  5.69           C  
ATOM     24  OD1 ASN A  27       4.076  -1.673  42.244  1.00  7.13           O  
ATOM     25  ND2 ASN A  27       4.303   0.300  43.162  1.00  5.70           N  
ATOM     26  N   LYS A  28       0.679  -0.562  41.111  1.00  6.74           N  
ATOM     27  CA  LYS A  28      -0.613  -0.107  41.660  1.00  7.37           C  
ATOM     28  C   LYS A  28      -0.782  -0.694  43.024  1.00  6.35           C  
ATOM     29  O   LYS A  28      -0.649  -1.891  43.181  1.00  5.98           O  
ATOM     30  CB  LYS A  28      -1.793  -0.608  40.818  1.00 10.05           C  
ATOM     31  CG  LYS A  28      -1.881  -0.124  39.397  1.00 13.08           C  
ATOM     32  CD  LYS A  28      -3.221  -0.537  38.789  1.00 15.61           C  
ATOM     33  CE  LYS A  28      -3.518   0.245  37.539  1.00 21.38           C  
ATOM     34  NZ  LYS A  28      -4.708  -0.310  36.806  1.00 21.78           N  
ATOM     35  N   GLY A  29      -1.073   0.130  44.016  1.00  6.55           N  
ATOM     36  CA  GLY A  29      -1.202  -0.406  45.339  1.00  6.36           C  
ATOM     37  C   GLY A  29      -2.292   0.271  46.105  1.00  5.27           C  
ATOM     38  O   GLY A  29      -2.486   1.454  46.005  1.00  5.35           O  
ATOM     39  N   ALA A  30      -2.955  -0.515  46.917  1.00  5.46           N  
ATOM     40  CA  ALA A  30      -3.876  -0.026  47.906  1.00  5.33           C  
ATOM     41  C   ALA A  30      -3.483  -0.651  49.233  1.00  4.81           C  
ATOM     42  O   ALA A  30      -3.435  -1.861  49.368  1.00  4.77           O  
ATOM     43  CB  ALA A  30      -5.269  -0.446  47.531  1.00  6.37           C  
ATOM     44  N   ILE A  31      -3.163   0.187  50.196  1.00  5.04           N  
ATOM     45  CA  ILE A  31      -2.776  -0.287  51.534  1.00  5.15           C  
ATOM     46  C   ILE A  31      -3.720   0.384  52.484  1.00  5.10           C  
ATOM     47  O   ILE A  31      -3.595   1.576  52.788  1.00  4.42           O  
ATOM     48  CB  ILE A  31      -1.338   0.064  51.912  1.00  5.73           C  
ATOM     49  CG1 ILE A  31      -0.381  -0.576  50.912  1.00  6.26           C  
ATOM     50  CG2 ILE A  31      -1.041  -0.460  53.290  1.00  5.92           C  
ATOM     51  CD1 ILE A  31       1.064  -0.295  51.191  1.00  6.96           C  
ATOM     52  N   ILE A  32      -4.675  -0.399  52.928  1.00  5.76           N  
ATOM     53  CA  ILE A  32      -5.861   0.141  53.495  1.00  6.89           C  
ATOM     54  C   ILE A  32      -6.082  -0.515  54.857  1.00  6.63           C  
ATOM     55  O   ILE A  32      -6.137  -1.709  54.942  1.00  6.46           O  
ATOM     56  CB  ILE A  32      -7.089  -0.100  52.574  1.00  9.87           C  
ATOM     57  CG1 ILE A  32      -6.804   0.449  51.176  1.00 10.65           C  
ATOM     58  CG2 ILE A  32      -8.335   0.500  53.214  1.00 12.70           C  
ATOM     59  CD1 ILE A  32      -7.938   1.062  50.419  1.00 16.92           C  
ATOM     60  N   GLY A  33      -6.206   0.306  55.895  1.00  9.17           N  
ATOM     61  CA  GLY A  33      -6.577  -0.150  57.226  1.00 12.74           C  
ATOM     62  C   GLY A  33      -7.997   0.265  57.540  1.00 13.72           C  
ATOM     63  O   GLY A  33      -8.306   1.453  57.515  1.00 13.74           O  
ATOM     64  N   LEU A  34      -8.849  -0.728  57.792  1.00 22.20           N  
ATOM     65  CA  LEU A  34     -10.201  -0.529  58.315  1.00 28.84           C  
ATOM     66  C   LEU A  34     -10.331  -1.076  59.764  1.00 27.99           C  
ATOM     67  O   LEU A  34     -11.207  -0.671  60.546  1.00 28.91           O  
ATOM     68  CB  LEU A  34     -11.250  -1.196  57.388  1.00 34.49           C  
ATOM     69  CG  LEU A  34     -11.866  -0.323  56.286  1.00 38.09           C  
ATOM     70  CD1 LEU A  34     -10.749   0.182  55.404  1.00 42.18           C  
ATOM     71  CD2 LEU A  34     -12.895  -1.058  55.438  1.00 40.02           C  
ATOM     72  OXT LEU A  34      -9.592  -1.961  60.205  1.00 30.29           O  
TER      73      LEU A  34                                                      
HETATM   74  O   HOH A 101      -0.080  -2.580  37.756  1.00 15.91           O  
MASTER      195    0    0    0    0    0    0    6   73    1    0    1          
END                                                                             
